|Title:||Corporate governance and the valuation of R&D|
|Subject:||Hong Kong Polytechnic University -- Dissertations|
Business -- Research
|Department:||School of Accounting and Finance|
|Pages:||vii, 179 leaves : ill. ; 30 cm.|
|Abstract:||The dissertation studies how corporate governance mechanisms influence the valuation of corporate research and development (R&D) investment. First, I examine how internal and external corporate governance affect the equity holders' valuation of R&D. Using a sample of U.S. firms from 1998 to 2006, I find that: (1) boards that are more independent and whose independent directors have more outside directorships are associated with higher R&D valuation; (2) less anti-takeover provisions (market control mechanism) are also associated with higher R&D valuation; and (3) effective board governance (market control mechanism) is associated with higher R&D valuation only in the presence of weak market control mechanism (board governance). My results provide evidence indicating that both internal and external governance enhance R&D valuation, but they substitute in doing so. Next, I focus on the effect of corporate board to enhance the R&D valuation. Effective corporate governance can enhance the market valuation of R&D either by increasing the expected future cash flows (numerator effect), by decreasing the cost of equity (denominator effect), or by both. Examining a sample of U.S. firms, I provide evidence suggesting that: (1) R&D expenditures are positively associated with expected future cash flows, and this positive association is higher with more effective corporate boards; and (2) firms with more R&D expenditures enjoy a lower cost of equity, and this relationship is stronger when corporate boards are more effective. My findings suggest that boards enhance R&D valuation through both increasing R&D-induced expected future cash flows and decreasing R&D-related cost of equity. Finally, I turn my focus from equity holders to debt holders. I first examine the relationship between R&D investments and cost of debt and then further explore boards' potential influence on it. I find that firms with more R&D expenditures are associated with lower credit ratings (a higher cost of debt), and further, boards that are more independent and whose independent directors have more outside directorships are associated with a less pronounced negative relationship between R&D expenditures and credit ratings.|
|Rights:||All rights reserved|
As a bona fide Library user, I declare that:
- I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
- I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
- I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.
Please use this identifier to cite or link to this item: